These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9403933)
1. Decrease in viral load associated with topical dinitrochlorobenzene therapy in HIV disease. Stricker RB; Goldberg B; Mills LB; Epstein WL Res Virol; 1997; 148(5):343-8. PubMed ID: 9403933 [TBL] [Abstract][Full Text] [Related]
2. Topical immune modulation with dinitrochlorobenzene in HIV disease: a controlled trial from Brazil. Traub A; Margulis SB; Stricker RB Dermatology; 1997; 195(4):369-73. PubMed ID: 9529559 [TBL] [Abstract][Full Text] [Related]
3. Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection. Stricker RB; Zhu YS; Elswood BF; Dumlao C; Van Elk J; Berger TG; Tappero J; Epstein WL; Kiprov DD Immunol Lett; 1993 Apr; 36(1):1-6. PubMed ID: 8102123 [TBL] [Abstract][Full Text] [Related]
4. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases. Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519 [TBL] [Abstract][Full Text] [Related]
5. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study. García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779 [TBL] [Abstract][Full Text] [Related]
6. Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. Bouscarat F; Levacher M; Landman R; Muffat-Joly M; Girard PM; Saimot AG; Brun-Vézinet F; Sinet M AIDS; 1998 Jul; 12(11):1267-73. PubMed ID: 9708405 [TBL] [Abstract][Full Text] [Related]
7. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy. Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977 [TBL] [Abstract][Full Text] [Related]
8. Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis. Moretti S; Alesse E; Marcellini S; Di Marzio L; Zazzeroni F; Parroni R; Famularo G; Boschini A; Cifone MG; De Simone C Immunopharmacol Immunotoxicol; 1999 Nov; 21(4):645-65. PubMed ID: 10584202 [TBL] [Abstract][Full Text] [Related]
9. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients. Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients]. Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327 [TBL] [Abstract][Full Text] [Related]
11. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy. García F; Plana M; Vidal C; Cruceta A; O'Brien WA; Pantaleo G; Pumarola T; Gallart T; Miró JM; Gatell JM AIDS; 1999 Jul; 13(11):F79-86. PubMed ID: 10449278 [TBL] [Abstract][Full Text] [Related]
20. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. Gray CM; Schapiro JM; Winters MA; Merigan TC AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]